cdmo.directory
← Compare landing

Experic vs Medpharm

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/expericservices/medpharm

CategoryExpericMedpharm
Listed sitecdmocdmo
SummarySpecialist powder-handling CDMO offering clinical trial supply, development, manufacturing, and packaging services for pharmaceutical products.Specialized CDMO for topical, transdermal, and transepithelial drug products offering formulation development, analytical testing, process scale-up, and GMP manufacturing from early development through commercialization.
Services
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Inhalation & Nasal Dosage Manufacturing
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • Quality Control Testing
  • Technology Transfer
  • Cold-Chain Storage & Logistics
  • Combination Product Assembly & Final Packaging
  • Formulation Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Process Development
  • Technology Transfer
  • Topical & Semi-Solid Manufacturing
  • Ophthalmic Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • Quality Control Testing
ModalitiesData not yet provided.
  • Small Molecule
IndicationsData not yet provided.
  • Dermatology
  • Ophthalmology
  • Respiratory
Locations
  • US Facility, United States
  • EU Facility, European Union
  • EU Facility, Europe
  • Headquarters, Guildford, England, United Kingdom
  • US Operations, Durham, North Carolina, United States
Certifications
  • FDA · Identifier: 21 CFR Parts 210, 211, 820
  • ICH · Identifier: Q7, Q9, Q10
  • EMA · Identifier: EudraLex Volume 4
  • ISO · Identifier: 13485:2016
  • DEA · Identifier: Schedules I–V
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.